The RxView Blog

Real world data, analytics, and insights for healthcare decision makers

Advera Health Analytics, Inc.

Chronic Underreporting of Clinical Trials

Posted by Brian Overstreet on July 8, 2016

Well, now we’re getting somewhere!

Read More

Topics: MS, NIH

3 Reasons a Clinical Evidence Database for Multiple Sclerosis is Important

Posted by Jim Davis on May 20, 2016

Oftentimes it’s hard for me to see the forest through the trees. Being responsible for the commercial outcome of what we are working to accomplish at Advera Health with an incredibly talented, albeit small, team can be daunting at best.  At worst it is completely insanely chaotic. Ensuring sales forecasts are accurate for board and investor meetings, directing the marketing strategy for product launches like this week’s announcement of our multiple sclerosis coverage, and working out the details of big partnerships like the one we will soon be announcing with a large, national group purchasing organization (GPO) requires a lot of attention to detail, acutely managed with a long to-do list.

Read More

Topics: patients, Clinical Evidence, Evidex, MS

Subscribe to Email Updates